Baroreflex activation therapy in hypertension.

about

Device-based Therapy for Hypertension Chronic Interactions Between Carotid Baroreceptors and Chemoreceptors in Obesity Hypertension Baroreceptor Stimulation for Resistant Hypertension.High-performance wireless powering for peripheral nerve neuromodulation systems.

P2860

Q26745518-AA339787-A6E4-44F3-8946-5E719867F87E Q36989367-FF21455C-A389-45EB-AC04-A405B3A77692 Q38905064-B853046B-EB9C-47E3-90AC-3BBFBB61FD28 Q45775462-0AFD3E65-A48C-4695-AC39-9D3BF9B4C8C6

P2860

Baroreflex activation therapy in hypertension.

Item

http://www.wikidata.org/entity/Q38183248

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Baroreflex activation therapy in hypertension.

@en

type

Item

label

Baroreflex activation therapy in hypertension.

@en

prefLabel

Baroreflex activation therapy in hypertension.

@en

P1476

Baroreflex activation therapy in hypertension.

@en

P2093

J D Bisognano

http://www.w3.org/2001/XMLSchema#string

J P Gassler

http://www.w3.org/2001/XMLSchema#string

P2860

Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.

Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008

Epilepsy surgery and vagal nerve stimulation: what all neurologists should know.

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.

A SURGICAL TREATMENT OF ESSENTIAL HYPERTENSION.

THE EFFECT ON THE KIDNEY OF BILATERAL SPLANCHNICECTOMY IN PATIENTS WITH HYPERTENSION.

Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study.

Prolonged activation of the baroreflex produces sustained hypotension.

P2888

jhh.2013.139

P304

469-474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JHH.2013.139

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1049997074

http://www.w3.org/2001/XMLSchema#string

P698

24477209

http://www.w3.org/2001/XMLSchema#string

Baroreflex activation therapy in hypertension.

about

P2860

P2860

Baroreflex activation therapy in hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698